Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Iterum Therapeutics plc:
We consent to the use of our report dated March 25, 2019 incorporated by reference herein and to the
reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG
Dublin, Ireland
July 5, 2019
